FDA Clearance Tracker · P230040-S010
Cordella Pulmonary Artery Sensor System (CorPASS)
Last checked: Nov 20, 2026Latest source record: Jan 17, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jan 17, 2025
Approved
Time to decision
30 days
Received Dec 18, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P230040-S010
- Device name
- Cordella Pulmonary Artery Sensor System (CorPASS)
- Applicant
- Endotronix, Inc.
- Applicant location
- Naperville, IL
- Received
- Dec 18, 2024
- Decided
- Jan 17, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P230040
Device type
- Device type
- System, hemodynamic, implantable (MOM)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
the post-approval enrollment timelines
Source documents
Other decisions for Endotronix, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P230040 · Decided Jun 20, 2024 · 190 days after receipt
Device type: System, hemodynamic, implantable (MOM) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.